Green Valley Pharmaceutical
Sheng Zhu has extensive experience in the pharmaceutical marketing sector, currently serving as Market Manager and Market Strategy Manager at 上海绿谷制药有限公司 since March 2018. Prior roles include Product Manager at 勃林格殷格翰 for a short tenure, and Senior Marketing Communications Manager at 卫材 from May 2015 to March 2018. Additional experience includes Senior Account Manager at Sudler & Hennessey, where responsibilities involved customer communication, team coordination, and proposal preparation, as well as an Account position at Reed Elsevier focused on sales of customized projects. Sheng Zhu began a career as Account Manager at Pharmaliaison, assisting in annual marketing strategies and budget management. Education includes a Bachelor's degree in Marketing & Management from Victoria University of Wellington, obtained in 2006.
This person is not in any teams
Green Valley Pharmaceutical
Shanghai Green Valley Pharmaceuticals is an innovative Chinese pharmaceutical company founded in 1997 that pioneers carbohydrate drug development and new treatment strategies in the areas of chronic and complex diseases. It is focused on advancing research programs in neuropsychiatric diseases, cancer, cardiovascular diseases, metabolic diseasesand autoimmune diseases. It has 1,500 employees in China and operates a subsidiary in the United States. It has built the large-scale carbohydrate compound library, the carbohydrate drug API and processing facility, and the world's leading R&D pipeline for carbohydrate drug products.The company upholds the sacred mission of "developing medicines that fulfill the biggest unmet medical needs for human health", explores the pathogenesis of chronic and complex diseases with a holistic view of treatment, and focuses on breakthrough innovation in research and development of carbohydrate drugs. Green Valley is committed to becoming a global leader in carbohydrate drug innovation, providing safer and more effective drugs for patients with chronic and complex diseases, and providing better choice of treatment for diseases and improving the quality of life.